Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMSB15A | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
mRNA | SUGP2 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-09 |
mRNA | CENPV | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
mRNA | RAD54L2 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
mRNA | LDOC1L | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
mRNA | DENND6A | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-09 |
mRNA | PAXBP1 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
mRNA | ATXN7L2 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
mRNA | KLHL23 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-09 |
mRNA | TIA1 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-09 |